Lee Biosolutions isolates marker for testicular cancer

Lee Biosolutions Inc. has expanded its line of biomarkers to include products used to track testicular cancer.
Based in Brentwood, Lee Biosolutions collects biological materials — human saliva, semen, urine and vaginal secretions, among others — and produces finished proteins, enzymes, biologicals, immuno-reagents and antibodies for life science research and clinical diagnostic testing. The company’s core business is diagnostic and Lee Biosolutions sells proteins and enzymes to research labs like the Cleveland Clinic and pharmaceutical companies such as Abbott Laboratories.

[St. Louis Business Journal]